Clinical Mobilty Technology - 18902 Doylestown, PA

Business Name: Clinical Mobilty Technology
Categorized In: Research and Development Laboratories
Address: 4527 Summerhill Drive, Doylestown, PA 18902
Phone Number: (215) 340-7771
Contact Person: Frank Abbott, President
NAICS Code: 4461990
SIC Code: 8731
Business Type: B2B (Business to Business)
Founding Year: 2013
Employee #: 1 to 4
Location Type: Single Location
Annual Revenue ($): $100.000 to $499.999
Share This Business:
Similar Businesses: Gfree Bio LLC - Doylestown, PA 18902
Shar-X Biopharma LLC - Doylestown, PA 18902
Fox Chase Chem Diversity Center - Doylestown, PA 18902
Alliance Discovery Inc - Doylestown, PA 18902
Serome Biosciences - Doylestown, PA 18902
Zasloff Laboratories - Doylestown, PA 18902
Toph Biologicals Inc - Doylestown, PA 18902
Alis Life Science LLC - Doylestown, PA 18902
Als Biopharma LLC - Doylestown, PA 18902
Captivate Pharmaceuticals - Doylestown, PA 18902
Jiffy Lid Technologies LLC - Doylestown, PA 18902
Pennsylvania Drug Discovery Institute - Doylestown, PA 18902
Cherry Pharmaceutical - Doylestown, PA 18902
Jbs Science Inc - Doylestown, PA 18902
Pharmabridge Inc - Doylestown, PA 18902
Immunotope Diagnostics Inc - Doylestown, PA 18902
Enantigen Therapeutics Inc - Doylestown, PA 18902

Clinical Mobilty Technology provides professional Research and Development Laboratories from its single location at the coordinates 40.350489,-75.122881.

The company offers B2B variables under the SIC code 8731 and NAICS code 4461990, while making an annual revenue of $100.000 to $499.999 and hiring a total of 1 to 4 employees.

Founded in 2013, the company can now be visited at 4527 Summerhill Drive, Doylestown, Pennsylvania 18902 or contacted through representative Frank Abbott, President at (215) 340-7771.

For frequently asked questions and further inquiries about professional Research and Development Laboratories, get to know more about Clinical Mobilty Technology through its company website at . Engage with this business on its social media platforms through on Twitter and on Facebook.